Optimized Treatment Strategy for HighGrade1 (HGT1) Bladder Cancer Based on Substaging: a Prospective Observational Cohort Study
CompletedOBSERVATIONAL
Enrollment
200
Participants
Timeline
Start Date
April 30, 2005
Primary Completion Date
December 31, 2013
Study Completion Date
December 31, 2013
Conditions
Bladder Cancer
Trial Locations (1)
08035
Hospital Vall d'Hebron, Barcelona, Spain, Barcelona
All Listed Sponsors
lead
Hospital Universitari Vall d'Hebron Research Institute
OTHER
NCT02113501 - Optimized Treatment Strategy for HighGrade1 (HGT1) Bladder Cancer Based on Substaging: a Prospective Observational Cohort Study | Biotech Hunter | Biotech Hunter